Overview
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
Status:
Completed
Completed
Trial end date:
2014-12-01
2014-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4 Gel administered once daily to 50 cm2 of skin for 14 days.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Topokine Therapeutics, Inc.
Criteria
Inclusion Criteria:- Men and women 40-70 years old
- Healthy volunteers
- Provision of informed consent
Exclusion Criteria:
- History of skin hypersensitivity
- Abnormality on screening assessments